Improvement in 3-month patient-reported gastrointestinal symptoms after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in renal transplant patients.

Improvement in 3-month patient-reported gastrointestinal symptoms after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in renal transplant patients.

Item
http://www.wikidata.org/entity/Q42640283
Current state of renal transplant immunosuppression: Present and futureDoes reduction in mycophenolic acid dose compromise efficacy regardless of tacrolimus exposure level? An analysis of prospective data from the Mycophenolic Renal Transplant (MORE) Registry.Improved gastrointestinal symptoms and quality of life after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in renal transplant patients receiving tacrolimus.Mycophenolic acid formulations in adult renal transplantation - update on efficacy and tolerability.Randomized trial of enteric-coated mycophenolate sodium versus mycophenolate mofetil in multi-system autoimmune disease.Impact of switching from mycophenolate mofetil to enteric-coated mycophenolate sodium on gastrointestinal side effects in patients with autoimmune disease: a Phase III, open-label, single-arm, multicenter studyCyclosporine Sparing Effect of Enteric-Coated Mycophenolate Sodium in De Novo Kidney Transplantation.Enteric-coated mycophenolate sodium: an update.Pharmacology and toxicology of mycophenolate in organ transplant recipients: an update.Advances in pharmacotherapy to treat kidney transplant rejection.Enteric-coated mycophenolate sodium given in combination with tacrolimus has a lower incidence of serious infections in Asian renal-transplant recipients compared with mycophenolate mofetil.Conversion to enteric-coated mycophenolate sodium from mycophenolate mofetil in stable renal transplant patients: results of an Asia-Pacific study.Enteric-coated mycophenolate sodium.Enteric-coated mycophenolate sodium in de novo and maintenance kidney-pancreas transplant recipients.Long-term dosing patterns of enteric-coated mycophenolate sodium or mycophenolate mofetil with tacrolimus after renal transplantation.Improvement of gastrointestinal symptoms after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in liver transplant patients.
P2860

Improvement in 3-month patient-reported gastrointestinal symptoms after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in renal transplant patients.

Item
http://www.wikidata.org/entity/Q42640283
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Improvement in 3-month patient ...... in renal transplant patients.
@en
Improvement in 3-month patient ...... in renal transplant patients.
@nl
type
label
Improvement in 3-month patient ...... in renal transplant patients.
@en
Improvement in 3-month patient ...... in renal transplant patients.
@nl
prefLabel
Improvement in 3-month patient ...... in renal transplant patients.
@en
Improvement in 3-month patient ...... in renal transplant patients.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P50
P577
P698
P921
P356
P1433
P1476
Improvement in 3-month patient ...... in renal transplant patients.
@en
P2093
P304
P31
P356
10.1097/01.TP.0000290678.06523.95
P433
P478
P50
P577
P698
P921